The global diabetes devices market was valued at USD 1.7 billion in 2021 and it is anticipated to grow up to USD 8.0 billion by 2031 at a CAGR of 16.7% during the forecast period.
Diabetes is a disorder that occurs when the blood glucose levels rise over normal levels, due to a defect in insulin production that controls glucose levels. Blood glucose acts as the main source of energy and can be obtained from the food we consume. Insulin, the pancreatic hormone maintains blood glucose levels. Defect in the synthesis of insulin in the body cannot regulate the blood glucose level and causes diabetes.
To Remain ‘Ahead’ Of Your Competitors, Request for A Sample –https://www.globalinsightservices.com/request-sample/GIS10117
The Blood glucose level range in a normal individual is 70 – 100 mg/dL and in a diabetic patient it raises up to 80 – 130 mg/dL. Diabetes care devices are employed to monitor the glucose levels of a diabetic patient. A continuous glucose monitor (CGM) is a medical device that tracks and monitors the blood glucose of a diabetic patient during the day.
Get A Customized Scope to Match Your Need Ask an Expert –https://www.globalinsightservices.com/request-customization/GIS10117
Global Diabetes Devices Market Scope and Report Structure
Market Trends and Drivers
The key factors such as an increase in the incidence of diabetes owing to aging, obesity, and unhealthy lifestyle is one of the factors contributing to the growth of the market. Obesity is a major factor leading to diabetes. According to WHO, in 2016, over 1.9 billion adults were overweight, of which, around 650 million people were obese. Risk factors, like obesity and overweight, are leading to a rise in the incidence of diabetes. Owing to that, risk factors like smoking, overweight, obesity, and high cholesterol levels are anticipated to boost the prevalence of diabetes, so fueling the need for diabetes devices.
For In-Depth Competitive Analysis, Purchase this Report –https://www.globalinsightservices.com/checkout/single_user/GIS10117
- Blood glucose monitoring systems
- Self-monitoring blood glucose monitoring systems
- Continuous glucose monitoring systems
- Test strips/Test papers
- Lancets/Lancing devices
- Insulin delivery devices
- Insulin pumps
- Insulin pens
- Insulin syringes and needles
- Diabetes management mobile applications
By End User
- Hospitals & Specialty Clinics
- Self & Home Care
New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/
Major Players in Diabetes Devices Market
The key players in the diabetes devices market are Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt. Ltd. (India), Ypsomed (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan).
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.